Advertisement

Topics

Medarex Company Profile

18:53 EDT 24th September 2017 | BioPortfolio

Medarex is an integrated monoclonal antibody-based company with antibody discovery, development and manufacturing capabilities. Utilizing its HuMAb-Mouse(TM) system, Medarex has the ability to make fully-human antibodies in a transgenic mouse whose mouse genes for creating antibodies have been inactivated and replaced by human antibody genes. The Company has entered into ten corporate partnering arrangements based on the HuMAb-Mouse system.

Location

707 State Road #206
Princeton
NJ
08540
United States of America

Contact

Phone: (609) 430-2880
Fax: 609-430-2850
Email: information@medarex.com


News Articles [2 Associated News Articles listed on BioPortfolio]

Medtronic’s Deal With Aetna Heralds New Value-Based Era

Medtronic's outcomes-based insulin pump supply deal with Aetna is the latest example of the medtech industry's shift toward value-based care.   

Sapience Therapeutics Adds Biotech Veteran, Christian S. Schade, to Board of Directors

SCARSDALE, NY--(Marketwired - May 10, 2017) - Sapience Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics to address difficult to treat oncology indications, announc...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [7 Associated Companies listed on BioPortfolio]

Medarex, Inc.

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating disea...

Medarex

Medarex is an integrated monoclonal antibody-based company with antibody discovery, development and manufacturing capabilities. Utilizing its HuMAb-Mouse(TM) system, Medarex has the ability to make fu...

Biolex, Inc

Biolex Therapeutics applies its unique drug development capabilities and expertise to commercialize complex proteins and monoclonal antibodies that until now have been impossible or very expensive to ...

Biolex, Inc.

Biolex Therapeutics applies its unique drug development capabilities and expertise to commercialize complex proteins and monoclonal antibodies that until now have been impossible or very expensive to ...

Oxford BioTherapeutics (OBT)

Oxford BioTherapeutics (OBT) is focused on the development of targeted antibody medicines for oncology. OBT's strategy is to develop innovative antibody-based cancer drugs, with integrated diagnos...

More Information about "Medarex" on BioPortfolio

We have published hundreds of Medarex news stories on BioPortfolio along with dozens of Medarex Clinical Trials and PubMed Articles about Medarex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medarex Companies in our database. You can also find out about relevant Medarex Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record